Vaso Corporation

VASO ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $1.6M $951.0K $4.8M $11.3M $6.1M $358.0K $-382.0K $-3.7M
Depreciation & Amortization $858.0K $824.0K $999.0K $1.9M $3.8M $2.5M $2.7M $2.5M
Depreciation $489.0K $463.0K $635.0K $1.4M $1.87B $1.56B $1.7M $1.5M
Amortization $369.0K $361.0K $361.0M $551.0K $2.0M $906.0M $943.0K $1.0M
Stock-Based Compensation $33.0K $54.0K $48.0K $35.0K $31.0K $88.0K $141.0K $313.0K
Net Cash from Operating Activities $9.3M $3.3M $5.3M $14.4M $7.8M $5.9M $-1.3M $-1.5M
Investing Activities
Capital Expenditures — — — $566.0K $415.0K $1.0M $1.2M $2.6M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-725.0K $11.7M $-5.7M $-8.4M $-260.0K $-575.0K $-1.2M $-2.3M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $248.0K $-89.0K $-134.0K $-230.0K $-8.3M $-553.0K $1.9M $1.1M
Net Change in Cash $8.8M $14.9M $-479.0K $5.8M $-794.0K $4.7M $-544.0K $-2.6M
Free Cash Flow — — — $13.9M $7.4M $4.9M $-2.5M $-4.0M
← Newer Page 1 of 2 Older →